We did a randomised controlled crossover trial to compare the efficacy of active OIT ( using characterised peanut flour ; protein doses of 2-800 mg/day ) with control ( peanut avoidance , the present standard of care ) at the NIHR/Wellcome Trust Cambridge Clinical Research Facility ( Cambridge , UK ) .